Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Zimmermann

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
MMW Fortschritte Der Medizin|November 14, 2018
[Hepatitis C: Innovations in the last 10 years]Johanna Pflaum, Tim Zimmermann
Zeitschrift Fur Gastroenterologie|November 16, 2020
Christoph Sarrazin, Tim Zimmermann, Stefan Zeuzem
Current Infectious Disease Reports|February 11, 2011
Posttransplant lymphoproliferative disease in liver transplant patientsChristina Hartmann, Marcus Schuchmann, Tim Zimmermann
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 24, 2013
Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantationJohanna Knapstein, Peter R Galle, Tim Zimmermann
Journal of Medical Case Reports|July 23, 2014
Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case reportJohanna Knapstein, Marcus A Wörns, Peter R Galle, et al.
Zeitschrift Fur Gastroenterologie|July 10, 2018
Tim Zimmermann, Petra Lynen Jansen, Christoph Sarrazin, et al.
Zeitschrift Fur Gastroenterologie|April 5, 2017
[Hepatic manifestation of a macrophage activation syndrome (MAS)]Michael Nagel, Andreas Schwarting, Beate K Straub, et al.
Journal of Human Genetics|May 28, 2003
Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)Andreas Lazar, Dirk Gründemann, Reinhard Berkels, et al.
Physical Review Letters|May 2, 2025
Dwarf Galaxies Imply Dark Matter Is Heavier than 2.2×10^{-21}  eVTim Zimmermann, James Alvey, David J E Marsh, et al.
Transplantation|November 5, 2010
Early steroid-free immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trialNina Weiler, Ina Thrun, Maria Hoppe-Lotichius, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
MMW Fortschritte Der Medizin|November 14, 2018
[Hepatitis C: Innovations in the last 10 years]Johanna Pflaum, Tim Zimmermann
Zeitschrift Fur Gastroenterologie|November 16, 2020
Christoph Sarrazin, Tim Zimmermann, Stefan Zeuzem
Current Infectious Disease Reports|February 11, 2011
Posttransplant lymphoproliferative disease in liver transplant patientsChristina Hartmann, Marcus Schuchmann, Tim Zimmermann
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 24, 2013
Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantationJohanna Knapstein, Peter R Galle, Tim Zimmermann
Journal of Medical Case Reports|July 23, 2014
Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case reportJohanna Knapstein, Marcus A Wörns, Peter R Galle, et al.
Zeitschrift Fur Gastroenterologie|July 10, 2018
Tim Zimmermann, Petra Lynen Jansen, Christoph Sarrazin, et al.
Zeitschrift Fur Gastroenterologie|April 5, 2017
[Hepatic manifestation of a macrophage activation syndrome (MAS)]Michael Nagel, Andreas Schwarting, Beate K Straub, et al.
Journal of Human Genetics|May 28, 2003
Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)Andreas Lazar, Dirk Gründemann, Reinhard Berkels, et al.
Physical Review Letters|May 2, 2025
Dwarf Galaxies Imply Dark Matter Is Heavier than 2.2×10^{-21}  eVTim Zimmermann, James Alvey, David J E Marsh, et al.
Transplantation|November 5, 2010
Early steroid-free immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trialNina Weiler, Ina Thrun, Maria Hoppe-Lotichius, et al.
Pageof 9